Nipro Pharma Of Japan To Market Generic Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's Nipro, through its drug making subsidiary, Nipro Pharma, plans to market about a dozen injection-type generic drugs for treating cancer